338 related articles for article (PubMed ID: 32963613)
1. Progress of immune checkpoint LAG-3 in immunotherapy.
Shan C; Li X; Zhang J
Oncol Lett; 2020 Nov; 20(5):207. PubMed ID: 32963613
[TBL] [Abstract][Full Text] [Related]
2. The promising immune checkpoint LAG-3: from tumor microenvironment to cancer immunotherapy.
Long L; Zhang X; Chen F; Pan Q; Phiphatwatchara P; Zeng Y; Chen H
Genes Cancer; 2018 May; 9(5-6):176-189. PubMed ID: 30603054
[TBL] [Abstract][Full Text] [Related]
3. Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint Molecules.
D'Arrigo P; Tufano M; Rea A; Vigorito V; Novizio N; Russo S; Romano MF; Romano S
Curr Med Chem; 2020; 27(15):2402-2448. PubMed ID: 30398102
[TBL] [Abstract][Full Text] [Related]
4. A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy.
Leone RD; Lo YC; Powell JD
Comput Struct Biotechnol J; 2015; 13():265-72. PubMed ID: 25941561
[TBL] [Abstract][Full Text] [Related]
5. Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4.
Qin S; Xu L; Yi M; Yu S; Wu K; Luo S
Mol Cancer; 2019 Nov; 18(1):155. PubMed ID: 31690319
[TBL] [Abstract][Full Text] [Related]
6. LAG-3 Inhibitors: Novel Immune Checkpoint Inhibitors Changing the Landscape of Immunotherapy.
Ibrahim R; Saleh K; Chahine C; Khoury R; Khalife N; Cesne AL
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509517
[TBL] [Abstract][Full Text] [Related]
7. The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time's a Charm.
Lecocq Q; Keyaerts M; Devoogdt N; Breckpot K
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374804
[TBL] [Abstract][Full Text] [Related]
8. The application of nanotechnology in immune checkpoint blockade for cancer treatment.
Deng H; Zhang Z
J Control Release; 2018 Nov; 290():28-45. PubMed ID: 30287266
[TBL] [Abstract][Full Text] [Related]
9. Application of PD-1 Blockade in Cancer Immunotherapy.
Wu X; Gu Z; Chen Y; Chen B; Chen W; Weng L; Liu X
Comput Struct Biotechnol J; 2019; 17():661-674. PubMed ID: 31205619
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic overview of immune checkpoints to support the rational design of their combinations in cancer immunotherapy.
Rotte A; Jin JY; Lemaire V
Ann Oncol; 2018 Jan; 29(1):71-83. PubMed ID: 29069302
[TBL] [Abstract][Full Text] [Related]
11. FcγR-Binding Is an Important Functional Attribute for Immune Checkpoint Antibodies in Cancer Immunotherapy.
Chen X; Song X; Li K; Zhang T
Front Immunol; 2019; 10():292. PubMed ID: 30863404
[TBL] [Abstract][Full Text] [Related]
12. Development of Cancer Immunotherapy Targeting the PD-1 Pathway.
Kamimura N; Wolf AM; Iwai Y
J Nippon Med Sch; 2019; 86(1):10-14. PubMed ID: 30918149
[TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint: The novel target for antitumor therapy.
Jiang X; Liu G; Li Y; Pan Y
Genes Dis; 2021 Jan; 8(1):25-37. PubMed ID: 33569511
[TBL] [Abstract][Full Text] [Related]
14. Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy.
Zhang W; Kong X; Ai B; Wang Z; Wang X; Wang N; Zheng S; Fang Y; Wang J
Front Oncol; 2021; 11():582664. PubMed ID: 34631507
[TBL] [Abstract][Full Text] [Related]
15. Understanding LAG-3 Signaling.
Chocarro L; Blanco E; Zuazo M; Arasanz H; Bocanegra A; Fernández-Rubio L; Morente P; Fernández-Hinojal G; Echaide M; Garnica M; Ramos P; Vera R; Kochan G; Escors D
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067904
[TBL] [Abstract][Full Text] [Related]
16. Immune checkpoint inhibitors win the 2018 Nobel Prize.
Huang PW; Chang JW
Biomed J; 2019 Oct; 42(5):299-306. PubMed ID: 31783990
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses.
Chen X; Pan X; Zhang W; Guo H; Cheng S; He Q; Yang B; Ding L
Acta Pharm Sin B; 2020 May; 10(5):723-733. PubMed ID: 32528824
[TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.
Herzberg B; Campo MJ; Gainor JF
Oncologist; 2017 Jan; 22(1):81-88. PubMed ID: 27534574
[TBL] [Abstract][Full Text] [Related]
19. LAG-3: from molecular functions to clinical applications.
Maruhashi T; Sugiura D; Okazaki IM; Okazaki T
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32929051
[TBL] [Abstract][Full Text] [Related]
20. Immune checkpoint biology in health & disease: Immune checkpoint biology and autoimmunity in cancer patients.
Van Mol P; Donders E; Lambrechts D; Wauters E
Int Rev Cell Mol Biol; 2024; 382():181-206. PubMed ID: 38225103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
